Salmonella is one of the most common food-borne pathogens. The CDC estimates that Salmonella causes about 1.35 million illnesses in the United States each year, resulting in 26,500 hospitalizations annually. Previously, subtherapeutic levels of antibiotics used for growth promotion could control enteric pathogens like Salmonella. However, concerns about antibiotic resistance have led to regulations and restrictions on the use of antibiotics in animal feed. As a result, the demand for antibiotic-free alternatives that control enteric pathogens has increased dramatically.
To meet this growing need, Amlan International offers innovative solutions that support poultry health and performance without the use of antibiotics.
NeutraPath®, available in select international markets, optimizes poultry production efficiency and economic performance through a proprietary blend of essential oils, medium-chain fatty acids, and Amlan’s thermally processed calcium montmorillonite. This synergistic formula works through multiple modes of action to improve intestinal health, boost feed efficiency, and reduce mortality in disease challenged birds.
NeutraPath: Proven to Inhibit Salmonella and Reduce Colonization
A study at the University of Arkansas evaluated NeutraPath’s ability to inhibit Salmonella enterica serovar Typhimurium PHL2020 isolate (ST-PHL2020) intestinal colonization in broiler chickens. The research demonstrated that NeutraPath effectively inhibits ST-PHL2020 colonization in various parts of the upper gastrointestinal tract using an in vitro model designed to simulates conditions of a live digestive environment.
The in vitro digestion model consisted of three compartments that were simulated to match the pH, enzymatic composition, and temperature of the crop, proventriculus, and intestinal section of the chicken gastrointestinal tract.
The lowest concentration of NeutraPath used in this model (0.25%) reduced ST-PHL2020 colonization in the proventriculus and intestinal compartments compared to the control. An increase of NeutraPath concentration led to increased inhibition of ST-PHL2020 colonization. The 0.5% treatment reduced colonization in the crop and there was no detectable colonization in the proventriculus and intestinal compartments.
The in vivo section of this study revealed that a 0.25% supplementation of NeutraPath resulted in a 2-log reduction of bacterial load in the cecal tonsils compared to the control. This dosage of NeutraPath also reduced total prevalence of Salmonella in the ceca to 58% compared to 100% in the control. The findings from this study suggest that the unique blend of Amlan’s mineral, select essential oils and medium chain fatty acids inhibited Salmonella spp. in vitro and decreased Salmonella spp. populations within the chicken ceca in vivo.
Downregulation of Salmonella Virulence Genes
In addition to the inhibitory effect on Salmonella growth, NeutraPath also displayed the ability to modulate virulence gene expression. ST-PHL2020 was grown in LB culture media with or without supplementation of 1mg/mL of NeutraPath for 12 hours.
After incubation, RNA was extracted, reverse-transcribed, and then subjected to qPCR to analyze the expression of several Salmonella virulence genes. The expression of hilA and invF in samples treated with 0.5g/mL of NeutraPath was downregulated 1.71 and 10.71-fold respectively when compared to the control. The hilA and invF genes are necessary for the assembly of the TTSS (Type III secretion system) within Salmonella that is responsible for delivering effector proteins into the cytoplasm of host cells to promote virulence and colonization. NeutraPath also downregulated the expression of sopB, sopE, and sipA compared to the control. These genes encode effector proteins that stimulate inflammation and enhance the efficiency of host cell invasion.
These findings demonstrate NeutraPath’s ability to inhibit bacterial colonization in the chicken gastrointestinal tract and to neutralize important virulence factors. The results suggest that NeutraPath can be a viable alternative to antibiotics for controlling enteric pathogens in poultry production. To learn more about NeutraPath, visit amlan.com
Related posts
